The Pharmaceutical Journal
Vol 271 No 7276 p704
22 November 2003

This article
Reprint
Photocopy

News summary

Related websites
Medicines reclassification/switching: Scopoderm TTS (more)

Scopoderm reclassification

Novartis Consumer Health has asked the Medicines and Healthcare products Regulatory Agency to reclassify Scopoderm TTS (hyoscine 1.5mg transdermal patch) from a prescription only medicine to a pharmacy medicine. It will be renamed Scopoderm 1.5mg Patch for pharmacy sale.